Transform your lab operations with our cutting-edge Laboratory Information Management System (LIMS) for pharmaceutical, medical devices, food & beverages, cosmetics, lifesciences and other regulated industries. AmpleLogic LIMS software is especially designed for sample management, equipment and inventory management of pharma laboratories. It can be used by analysts for laboratory method execution. Laboratory Information Management System helps laboratories keep track of their standardized processes.

LIMS Software Podcast | Amplelogic

🌱 Optimizing Growth and Metabolite Production in Medical Cannabis: The Power of Light 🌟
In this episode, we explore insights from the scientific article titled "The role of red and white light in optimizing growth and accumulation of plant specialized metabolites at two light intensities in medical cannabis (Cannabis sativa L.)" published in Frontiers in Plant Science.
Using AI to analyze and summarize the research, we uncover how light quality and intensity influence the growth, physiology, and metabolite production in medical cannabis. Discover how specific combinations of red and white light can optimize both plant growth and the synthesis of therapeutic compounds.

🔬 Key Highlights:

The impact of red and white light on cannabis physiology and metabolism.
Effects of light intensity on cannabinoid and terpene production.
Practical implications for advancing cannabis cultivation practices.
Whether you're a researcher, cultivator, or simply curious about cannabis science, this AI-powered discussion delivers cutting-edge knowledge to enhance understanding and innovation in medicinal cannabis.

🎙️ Tune in now and join the conversation about the future of cannabis cultivation.

#CannabisScience #MedicinalCannabis #LightOptimization #Cannabinoids #AIinResearch

The role of red and white light in optimizing growth and accumulation of plant specialized metabolites at two light intensities in medical cannabis (Cannabis sativa L.)

Harris Fleming - Explainer Sample

We’re thrilled to welcome  Emmanuel Walckenaer, CEO of Yseop, back to AI Uncovered for a follow-up conversation on the rapid evolution of AI in biopharma. Since his last appearance, the industry has made significant strides in harnessing AI for regulatory submissions, clinical workflows, and medical writing—areas where Yseop is leading the charge in transforming content generation.

In this episode, Tim and Emmanuel revisit the biggest AI breakthroughs of 2024 and explore how the pharmaceutical sector is shifting from skepticism to large-scale adoption. They discuss real-world success stories, the growing impact of federated data sharing, and what companies should prioritize as they plan for 2025 and beyond.

With his unique perspective on SaaS growth, AI regulation, and enterprise adoption, Emmanuel provides invaluable insights for professionals navigating the intersection of AI and life sciences. If you're looking to understand the next wave of AI-driven innovation in pharma, this is an episode you won't want to miss.

Emmanuel Walckenaer - AI’s Real-World Impact on Pharma & What’s Next in 2025

Welcome to Addis Fortune’s weekly newsletter, your source for the week's crucial business and economic developments. From the financial woes gripping the Ethiopian Premier League and the cotton industry, to the regulatory uncertainties surrounding AliExpress's market entry, we explore the pressing issues impacting key sectors. We also examine the pharmaceutical manufacturers' moves for a tripartite loan fund and the complex financial picture emerging from Bunna Bank's latest performance report, revealing the strains of inflation and regulatory pressures.

Addis Fortune Weekly Digest Vol. 24, No. 1295

Paul Carpenter, a pharmaceutical innovator from Newtown, CT, is transforming natural healthcare with his groundbreaking nasal sprays. As the founder of New Leaf Pharmaceutical, he has developed all-natural solutions for headaches, allergies, congestion, and even anxiety. Paul Carpenter Shares five key health benefits of nasal sprays, including fast-acting relief, natural alternatives to pills, and support for anxiety and post-concussion recovery. With a commitment to innovation, he continues to explore new ways to harness the power of nasal delivery for overall wellness. His latest innovation, Rhinodol, is proving to be a game-changer for those seeking effective, non-addictive relief.

Paul Carpenter Shares 5 Health Benefits of Nasal Sprays

We’re excited to welcome Oeystein Kjoersvik to AI Uncovered. Oeystein leads the Generative AI program within the Quality Assurance team at Merck, where he focuses on developing AI tools and applying a quality-first approach to ensure safe, effective use of AI in GxP-regulated environments.

In this episode, Tim and Oeystein delve into the challenges of adopting AI in regulated settings, the complexity of validating GenAI tools, and the transition from traditional processes to AI-augmented systems. They also explore Oeystein’s work with the IMPALA Consortium and the importance of cross-industry collaboration to identify and scale high-value use cases for Generative AI.

Before his current role, Oeystein served as a Product Owner in Analytics at Merck IT, building analytics platforms and integrating data science across systems. He also contributed as a Machine Learning Subject Matter Expert to TransCelerate’s Intelligent Automation Group, advancing AI applications in pharmacovigilance.

Oeystein brings a rare blend of technical expertise and regulatory insight. He’s passionate about helping teams adopt AI responsibly and transparently—ensuring innovation aligns with quality across the pharmaceutical landscape.

Oeystein Kjoersvik - Auditing AI: Quality, Compliance & the Role of GenAI in Pharma

A calm, trustworthy voice guiding you through the science. This pharmaceutical sample is crafted for national campaigns — from patient awareness to provider messaging.

Cardiovia | Pharmaceutical Voice Sample

Background instrumental soundtrack for commercial use: with a bend towards medical, science, experimental and health related products

In The Lab

We welcome Karla Childers to AI Uncovered. Karla is a long-standing leader in bioethics and data transparency in the pharmaceutical industry. As part of the Office of the Chief Medical Officer at Johnson & Johnson, she brings deep expertise in navigating the ethical implications of emerging technologies, especially artificial intelligence, in medicine and drug development.

In this episode, Tim and Karla explore the intersection of AI, bioethics and patient-centered development. They discuss how existing ethical frameworks are being challenged by the rise of generative AI and why maintaining human oversight is critical—especially in high-context areas like clinical trial design, consent and medical communications. Karla also shares her views on the future of data privacy, the complexity of patient agency and how to avoid losing trust in the race for efficiency.

Karla is a strong advocate for using innovation responsibly. From her work with internal bioethics committees to her perspective on evolving regulatory expectations, she offers bold insights into how the industry can modernize without compromising ethics or equity.

Karla Childers - Ethical Guardrails for AI in Pharma

Welcome to AI Uncovered, a podcast for technology enthusiasts that explores the intersection of generative AI, machine learning, and innovation across regulated industries. With the AI software market projected to reach $14 trillion by 2030, each episode features compelling conversations with an innovator exploring the impact of generative AI, LLMs, and other rapidly evolving technologies across their organization. Hosted by Executive VP of Product at Yseop, Tim Martin leads a global team and uses his expertise to manage the wonderful world of product.

Paul Carpenter, a Pharmaceutical Executive from Newtown, CT, was inspired by a family remedy to create groundbreaking natural healthcare solutions. He developed the first all-natural nasal sprays for headaches, allergies, and congestion, making them widely available worldwide. Now, as the driving force behind New Leaf Pharmaceutical, he’s pioneering Rhinodol, an innovative nasal spray designed to relieve anxiety and post-concussion symptoms. Committed to advancing natural medicine, Paul continues to develop effective, science-backed treatments that improve lives.

Voice talent ready to work on your radio or TV spots, narration, explainer videos, audio books, voicemail, corporate, or internet project. Reach me at hflemingvo@gmail.com or visit harrisflemingvo.com.

I bring stories to life through bold, soulful voiceovers with an empowering edge. From commercial campaigns to podcast narration, I’m the confident voice behind brands that want to move people.

Voice of bold, soulful storytelling. From affirming gifts to podcast narration, I bring words to life—with purpose and power.

The medical cannabis sector is a dynamic and rapidly evolving field that captivates me for two primary reasons: the swift advancement of cultivation practices and technologies, and the complex challenges in refining and standardizing cultivation processes to elevate medical cannabis to the standards of contemporary pharmaceuticals.

My academic journey, encompassing both bachelor's and master's degrees, has been largely centred on the study of Cannabis sativa L. I have dedicated significant effort toward internships, thesis research, and academic consultancy training, where I have applied a range of theoretical frameworks to its cultivation. The personal experience of witnessing a relative manage pain with prescribed opioids galvanized my commitment to fostering progress in the cultivation of medical cannabis, offering a compassionate and promising alternative in pharmaceuticals.

Looking ahead, I am eager to collaborate with experts in the field, sharing knowledge, honing my expertise, and acquiring new competencies. I value networking and the exchange of diverse perspectives. My perpetual drive for growth and my aspiration to support others in enhancing their cultivation endeavors mean I am always open to connecting.

Feel free to reach out if you're interested in a conversation or collaboration.

New tracks tagged #pharmaceutical